COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,757 Articles (22,502 medRxiv, 8,255 bioRxiv)

Most recent first Previous |  Page 138: Articles 1371-1380  | Next

The SARS-CoV-2 nucleocapsid protein inhibits the cellular Nonsense-Mediated mRNA Decay (NMD) pathway preventing the full enzymatic activation of UPF1.
Nuccetelli, V., Mghezzi-Habellah, M., Deymier, S., Roisin, A., Gerard-Baraggia, F., Rocchi, C., Coureux, P.-D., Gouet, P., Cimarelli, A., Mocquet, V., Fiorini, F.
10.1101/2024.07.16.603692 — Posted: 2024-07-16
SARS-CoV-2 entry and fusion are independent of ACE2 localization to lipid rafts
Bolland, W., Buchrieser, J., Schwartz, O., Casartelli, N., Porrot, F., Guivel-Benhassine, F., Marechal, I., Petiot, C.
10.1101/2024.07.13.603361 — Posted: 2024-07-16
Effect of the COVID-19 pandemic and maternal SARS-CoV-2 status on breastfeeding practices in the COMBO cohort
Walzer, L., Nichols, P., Amoo-Achampong, M. K., Glassman, M. E., Kyle, M. H., Hussain, M., Abreu, W., Scripps, T., Khan, A., Hanft, E., Xu, R. L., LoFrumento, M. A., Kataria, A., Stockwell, M. S., Dumitriu, D., Fernandez, C. R.
10.1101/2024.07.14.24309868 — Posted: 2024-07-15
Clinical and cost-effectiveness of diverse post-hospitalisation pathways for COVID-19: A UK evaluation utilising the PHOSP-COVID cohort
Briggs, A. H., A, I., Walters, A., Houchen-Wolloff, L., Armstrong, N., Emerson, T., Gill, R., Hastie, C., Little, P., Overton, C., Pimm, J., Poinasamy, K., Singh, S., Walker, S., Leavy, O., Richardson, M., Elneima, O., McAuley, H., Shikotra, A., Singapuri, A., Sereno, M., Saunders, R., Harris, V., Greening, N., Harrison, E., Docherty, A., Lone, N., Quint, J., Chalmers, J., Ho, L.-P., Horsley, A., Raman, B., Wain, L., Brightling, C., Marks, M.
10.1101/2024.07.15.24310151 — Posted: 2024-07-15
Early combination of sotrovimab with nirmatrelvir/ritonavir or remdesivir is associated with low rate of persisting SARS CoV-2 infection in immunocompromised outpatients with mild-to-moderate COVID-19: a prospective single center study.
Gentile, I., Viceconte, G., Cuccurullo, F., Pietroluongo, D., D'Agostino, A., Silvitelli, M., Mercinelli, S., Scotto, R., Grimaldi, F., Palmieri, S., Gravetti, A., Trastulli, F., Moccia, M., Buonomo, A. R.
10.1101/2024.07.15.24310384 — Posted: 2024-07-15
Mutational and evolutionary dynamics of non-structural and spike proteins from variants of concern (VOC) ofSARS-CoV-2 in India
Chaudhuri, A., Das, S., Chakrabarti, S.
10.1101/2024.07.14.603481 — Posted: 2024-07-15
Rate variation and recurrent sequence errors in pandemic-scale phylogenetics
De Maio, N., Willemsen, M., Guo, Z., Saha, A., Hunt, M., Ly-Trong, N., Minh, B. Q., Iqbal, Z., Goldman, N.
10.1101/2024.07.12.603240 — Posted: 2024-07-15
p16High immune cell - controlled disease tolerance as a broad defense and healthspan extending strategy
Triana-Martinez, F., Pierantoni, A., Graca, D., Bergo, V., Emelyanov, A., Grigorash, B., Tsuji, S., Nakano, S., Grosse, L., Brglez, V., Marty, P., Dellamonica, J., Fornace, A. J., Trompouki, E., Eiji, H., Seitz-Polski, B., Bulavin, D. V.
10.1101/2024.07.15.603540 — Posted: 2024-07-15
Supervised Deep Learning with Gene Annotation for Cell Classification
Lin, Z., Sun, W.
10.1101/2024.07.15.603527 — Posted: 2024-07-15
Comparative Analysis of RT-PCR, RT-LAMP, and Antigen Testing Strategies for Effective COVID-19 Outbreak Control: A Modeling Study
Chantanasaro, T., Sararat, C., Yolai, N., Suttirat, P., Nawattanapaiboon, K., Chauvatcharin, S., Chadsuthi, S., Modchang, C.
10.1101/2024.07.14.24310377 — Posted: 2024-07-15

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).